Table 1.
Demographic and Basic clinical features of the study groups.
| Control group (n = 49) | Nonobese PCOS group (n = 45) | Obese PCOS group (n = 45) | p value | |
|---|---|---|---|---|
| Age (year) | 23.68 ± 2.2a | 24.12 ± 3.25a | 23.11 ± 2.88a | 0.760 |
| Waist-hip ratio (cm) | 0.69 ± 0.05b | 0.074 ± 0.06b | 0.96 ± 0.02a | 0.001 |
| Weight (kg) | 66.18 ± 6.6b | 67.2 ± 4.3b | 79.23 ± 3.2a | 0.001 |
| Height (cm) | 166.11 ± 5.5b | 164.24 ± 4.65b | 158.2 ± 5.2a | 0.001 |
| BMI (kg/m2) | 23.24 ± 2.2b | 24.34 ± 2.45b | 30.21 ± 1.2a | 0.001 |
| SBP(mmHg) | 114.42 ± 12.1b | 112.32 ± 10.21b | 132.2 ± 8.8a | 0.001 |
| DBP (mmHg) | 73.21 ± 8.23b | 75.22 ± 7.77b | 84.23 ± 4.4a | 0.001 |
| Menstrual cycle (day) | 23.11 ± 4.2c | 54.16 ± 16.6b | 69.44 ± 18.7a | 0.001 |
| FGS | 5.32 ± 1.23c | 9.65 ± 2.23b | 12.45 ± 3.67a | 0.001 |
a: significantly different from the obese PCOS group and the nonobese PCOS group (p < 0.05). b: significantly different from the obese PCOS group and controls (p < 0.05). c: significantly different from the nonobese PCOS group and controls (p < 0.05). Values are expressed as mean ± SD. Statistical significance was defined as p < 0.05. FGS: Ferriman–Gallwey score.